David J. Gladstone

机构：Dartmouth–Hitchcock Medical Center, Sunnybrook Health Science Centre · ORCID：0000-0003-0612-5544

发表论文 211 篇 · 总被引 16719 次 · h-index 54

代表论文

• Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy (2024 · JAMA · 被引 199)
• Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial (2024 · The Lancet · 被引 134)
• Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis (2023 · Stroke · 被引 73)
• Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials (2023 · The Lancet Neurology · 被引 65)
• Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial (2025 · The Lancet Neurology · 被引 50)
• Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke (2023 · JAMA Neurology · 被引 42)